Abstract
The process of drug discovery in the pharmaceutical industry often begins with the setting up of a bioassay whereby many thousands of synthetic compounds, or less characterized substances such as natural product extracts, may be screened in high throughput mode. During the early 1990s, we started a search using this approach for inhibitors of the cytokine Interleukin 6 (IL-6). One of the sources for screening was extracts of marine organisms provided to the former Ciba-Geigy organization by Harbor Branch Oceanographic Institute (HBOI). This chapter describes the finding of activity inhibiting IL-6 function from an extract of the marine sponge Callyspongia sp., and work which was carried out during the effort to characterize this activity more fully.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Hirano, T. and Kishimoto, T. 1992. Molecular biology and immunology of interleukin-6 (46th Forum in Immunology). Res. Immunol. 143:723
Hirano, T. 1992. Interleukin-6 and its relation to inflammation and disease. Clin. Immunol & Immunopathol. 62:860.
Breen, E.C., Rezai, A. R., Nakajima, K., Beall, G.N., Mitsuyasu, R.T., Hirano, T., Kishimoto, T. and Martinez-Maza, 0. 1990. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 144:480.
Jilka, R.L., Hangoc, G., Girasole, G., Passeri, G., Williams, D.C., Abrams, J., Boyce, B., Broxmeyer, H. and Manolagas, S. 1992. Increased osteoclast development after estrogen loss: mediation by Interleukin-6. Science 257:88.
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T. and Kishimoto, T. 1989. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573.
Simpson, R.J., Hammacher, A., Smith, D.K., Matthews, J.M. and Ward, L.D. 1997. Interleukin-6: structure-function relationships. Protein Sci. 6:929
Murakami, M., Hibi, M., Nakagawa, N., Nagakawa, T., Yasukawa, K., Yamanishi, K, Taga, T. and Kishimoto, T. 1993. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260:1808.
Hirano, T., Nakajima, K. and Hibi, M. 1997. Signaling mechanisms through gp 130: a model of the cytokine system. Cytokine & Growth Factor Rev. 8:241.
Heinrich, P.C., Bchrmann, I., Muller-Newen, G., Scahper, F. and Graeve, L. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334:297.
Taga, T., Kawanishi, K., Hardy, R.R., Hirano, T. and Kishimoto, T. 1987. Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression. J. Exp. Med. 166:967.
Peppard, J.V., Loo, P., Sills, M.A.., Munster, D., Pompon, S.A. and Wright, A. E. 1996. Characterization of an interleukin 6 cytokine family antagonist protein from a marine sponge, Callyspongia sp. J Biol. Chem. 271:7281.
Pomponi, S.A. 1976. A cytological study of the Haliclonidae and the Calyspongiidae (Porifera, Desmospongiae, Haplosclerida). In: “Aspects of Sponge Biology”, Eds. F.W. Harrison and R.R. Cowden, Academic Press.
Peppard, J.V., Smith, H.D. and Zhou, S. 1994. Kinetics of a cellular response to Interleukin 6. Cell. Immunol. 155:253.
Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami. T„ Nakahata, T., Hirabayashi, T., Yoneda, Y., Tanaka, K., Wang, W.Z, Mori, C., Shiota, K., Yoshida, N. and Kishimoto, T. 1996. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. U.S.A. 93:407.
Betz, U.A.K., Bloch, W., van den Broeck, M., Yoshida, K., Taga, T. Kishimoto, T., Addicks, K., Rajewsky, K. and Muller, W. 1998. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunolgocial, hepatic and pulmonary defects. J. Exp. Med. 188: 1955.
Yamamori, T. and Sarai, A. 1992. Coevolution of cytokine receptor families in the immune and nervous system. Neurosci. Res. 15: 151.
Kallen, K-J., Grotzingcr, J., Lelievre E., Vollmer, P., Aasland, D., Renne, C., Mullberg, J., Meyer zum Buschenfelde, K-H., Gasean, H. and Rose-John, S. 1999. Receptor recognition sites of cytokines are organized as exchangeable modules. J. Biol. Chem. 274:11859.
Huang, Y.W. and Vitetta, E.S. 1995 Immunotherapy of multiple myeloma. Stem Cells 13:123.
Brackenhoff, J.P.J., de Hon. F.D., Fontaine, V., ten Boekel, E., Schooltink, H., Rose-John, S., Heinrich, P.C., Content, J. and Aarden, L.A. 1994. Development of a human interleukin-6 receptor antagonist. J Biol. Chem. 269: 86.
Sporcno, E., Savino, R., Ciapponi, L., Paonessa, G., Cabibo, A., Lahm, A., Pulkki, K., Sun, R-X., Toniatti, C., Klein, B. and Cilikberto, G. 1996. Human Interleukin-6 receptor super-antagonists with high potency and wide spectrum on multiple myeloma cells. Blood 87:4510.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Peppard, J.V. et al. (2001). The Discovery and Characterization of an Interleukin 6 Cytokine Family Antagonist Protein from A Marine Sponge, Callyspongia sp. . In: Beck, G., Sugumaran, M., Cooper, E.L. (eds) Phylogenetic Perspectives on the Vertebrate Immune System. Advances in Experimental Medicine and Biology, vol 484. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1291-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1291-2_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5481-9
Online ISBN: 978-1-4615-1291-2
eBook Packages: Springer Book Archive